These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8232785)

  • 21. [Initial experiences in the use of intravenous immunoglobulins in Guillain-Barré-Strohl syndrome].
    Ceccarelli M; Pifferi M; Simoni F; Lupetti L; Ughi C
    Pediatr Med Chir; 1987; 9(6):719-21. PubMed ID: 3444744
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effect of high-dose gammaglobulin on a case of Guillain-Barré syndrome].
    Ishikawa A; Tanaka S; Fukushima N; Takase A; Wagatsuma Y; Kikuta H; Azuma H
    No To Hattatsu; 1993 May; 25(3):263-6. PubMed ID: 7686017
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Use of intravenous immunoglobulins in Guillain-Barré syndrome].
    Ceccarelli M; Assanta N; Chiaravalloti G; Rocopou C; Caiulo VA
    Minerva Pediatr; 1992 May; 44(5):237-40. PubMed ID: 1620076
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Single-dose intravenous immune globulin for treatment of Guillain-Barré syndrome.
    McGhee B; Jarjour IT
    Am J Hosp Pharm; 1994 Jan; 51(1):97-9. PubMed ID: 8135270
    [No Abstract]   [Full Text] [Related]  

  • 25. High-dose intravenous immune globulin in the management of severe Guillain-Barre syndrome.
    Baskin E; Turkay S; Icagasioglu D; Tanzer F; Cevit O
    Turk J Pediatr; 1996; 38(1):119-23. PubMed ID: 8819632
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barré syndrome. Dutch Guillain-Barré Study Group.
    van der Meché FG; Schmitz PI
    N Engl J Med; 1992 Apr; 326(17):1123-9. PubMed ID: 1552913
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Treatment of the Guillain-Barre syndrome with intravenous gammaglobulin. Presentation of a case].
    Barriales V; Velasco L; Moral A; Sánchez Navarro J
    Med Clin (Barc); 1990 Mar; 94(10):399. PubMed ID: 1692387
    [No Abstract]   [Full Text] [Related]  

  • 28. [Preventive and therapeutic use of intravenous administration of immunoglobulins in intensive care patients in pediatrics].
    Leititis JU
    Infusionsther Transfusionsmed; 1993 Apr; 20 Suppl 1():29-34. PubMed ID: 8499748
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Guillain-Barré syndrome after renal transplantation: a case of clinical success with intravenous immunoglobulin therapy.
    Bouza-Piñeiro P; Pego R; Alonso A; de la Fuente R; Martul EV
    Nephron; 1996; 74(1):223-4. PubMed ID: 8883048
    [No Abstract]   [Full Text] [Related]  

  • 30. Intravenous immunoglobulin treatment in children with Guillain-Barre syndrome.
    Gürses N; Uysal S; Cetinkaya F; Işlek I; Kalayci AG
    Scand J Infect Dis; 1995; 27(3):241-3. PubMed ID: 8539548
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of Guillain-Barré syndrome with anti-T cell monoclonal antibodies.
    Feasby TE
    J Neurol Neurosurg Psychiatry; 1991 Jan; 54(1):51-4. PubMed ID: 1901348
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chronic inflammatory polyneuropathy associated with nephropathy and antifactor VIII antibody: improvement with intravenous immunoglobulin.
    Fève AP; Smadja D; Rancurel G; Lèger JM
    J Neurol Neurosurg Psychiatry; 1992 Oct; 55(10):975-6. PubMed ID: 1431966
    [No Abstract]   [Full Text] [Related]  

  • 33. Guillain-Barré syndrome after heart transplantation.
    Baldwin RT; Pierce RR; Frazier OH
    J Heart Lung Transplant; 1992; 11(4 Pt 1):817-9. PubMed ID: 1323331
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recurrent Guillain-Barré syndrome.
    Roxburgh RH; Young AC
    Br J Hosp Med; 1996 Oct 2-15; 56(7):369-70. PubMed ID: 8899229
    [No Abstract]   [Full Text] [Related]  

  • 35. 'Immunoglobulin therapy in Guillain-Barré syndrome in children'.
    Ganesan V; Kirkham FJ
    Dev Med Child Neurol; 1996 Apr; 38(4):371-2. PubMed ID: 8641543
    [No Abstract]   [Full Text] [Related]  

  • 36. IVIg for GBS: potential problems in the alphabet soup.
    Bleck TP
    Neurology; 1993 May; 43(5):857-8. PubMed ID: 8492935
    [No Abstract]   [Full Text] [Related]  

  • 37. Guillain-Barré as an autoimmune disease.
    Shoenfeld Y; George J; Peter JB
    Int Arch Allergy Immunol; 1996 Apr; 109(4):318-26. PubMed ID: 8634515
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [New aspects of the pathogenesis and therapy of Guillain-Barré syndrome and chronic polyneuritis].
    Hartung HP; Heininger K; Toyka KV
    Nervenarzt; 1990 Apr; 61(4):197-207. PubMed ID: 2191228
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Guillain-Barré syndrome in children.
    Jones HR
    Curr Opin Pediatr; 1995 Dec; 7(6):663-8. PubMed ID: 8776016
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changing views of Guillain-Barré syndrome.
    Asbury AK; McKhann GM
    Ann Neurol; 1997 Mar; 41(3):287-8. PubMed ID: 9066348
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.